ExoCoBio Competitors and Similar CompaniesClear all

Gamida Cell's competitors and similar companies include Innate Pharma and OncoDNA.
Gamida Cell
Gamida Cell
Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.
Innate Pharma
Innate Pharma
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
OncoDNA
OncoDNA
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
Founding Date
Founding Date
1998
Founding Date
1999
Founding Date
2012
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Boston, US HQ
Jerusalem, IL
Locations
Marseille, FR HQ
Rockville, US
Locations
Charleroi, BE HQ
Employees
Employees
143175% increase
Employees
181
Employees
502% increase
Valuation ($)
Valuation ($)
4.3 m
Valuation ($)
148.6 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$1.8m (FY, 2023)
Revenue (est.)
€2.8m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$1.5m (FY, 2023)
Cost of goods
€266k (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$330k (FY, 2023)
Gross profit
€8.7m (FY, 2025)
Gross profit
N/A
Net income
Net income
($63m) (FY, 2023)
Net income
(€49.2m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 128.3m
Total funding raised
$ 94.1m
Total funding raised
$ 29.8m
For sources of this data, please see the company profile

View Company Profiles

Innate Pharma
HQ
Marseille, FR
Employees
181

Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.

View company
OncoDNA
HQ
Charleroi, BE
Employees
50↑ 2% increase

OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.

View company